GSK’S Introduction

•3rd largest pharmaceutical company in the world based on

revenues

•Leading market share in 4 of the 5 largest therapeutic markets

•5 % of the global pharmaceuticals market.

•1,100 prescriptions are written for one of its products every

minute.

•Spends over $450,000 every hour on R & D.

Company profile

Chairman: Sir Christopher Gent

•Headquarters: London, UK

•Global operations: Over 115 countries

•Stock Listing: Primary - London Stock Exchange

Secondary – New York Stock Exchange

•Revenue (2010): £ 28.4 billion

GSK’s Mission

SIMPLYFY

GROW

DELIVER

MISSION

GSK MISSION

Products

1. Prescription medicines

2. Vaccines

3. Consumer Healthcare

Consumer care products Vaccines

Medicines

PRESCRIPTION MEDICINES

ALLI-WEIGHT LOSS DRUG

AVANDIA-DIABETIS CONTROL

VACCINE FOR MEASLES

CONSUMER HEALTHCARE PRODUCTS

Corporate Culture

• Working at GSK• Engaging and developing employees• Diversity• Improving health and safety• Core values• Collaboration with doctors

New Market Entrants :• Recognized Marketing Code

Barriers to Entry :• Government policy• Brand Recognition

Competitive Priority :• Highly Competitive• Low Fixed Costs & High

Working Capital• Differentiation Strategy

Buyers Powers :• Consumers do not have

bargaining power.• Price sensitivity is less.• Brand identity in the hands

of influencer.

Power of Product and Technology Development :• Reforming R & D• Entrants of New Vaccines by 2011 end.• Restructuring for Diversity and

Strengthening.

Porters Five Forces Model for Developing Countries

(Porter, 2008)

Marketing

• Marketing strategy changes according to the region where the group is providing its products.

• GSK’s marketing strategy is different they always innovate new medicines as well as they enhance its old products with mild alterations and deliver it to the consumer accordingly

Entry Modes

• Licensing agreements• Joint ventures• Wholly owned Subsidiaries• Acquisitions

Where GSK stands Globally

• GSK has largest global presence in over 115 countries• Employed 99,000 people with12,500 in R&D• 7% share of Global market• Fourth largest pharmaceutical company

World market by geographic region

value(billion pounds) % of total• USA 187 40• Europe 131 28• France 25 5• Germany 24 5• Italy 16 3• UK 12 3• Rest of World 150 32• Emerging markets 66 14• Asia Pacific 20 4• Japan 50 11• Canada 11 2

Partnerships

• NHS• Non profit- organizations • The academic world

Global partnerships

• In September 2011, GSK and the McLaren Group joined forces to share knowledge and expertise with the aim of improving business performance and driving a more dynamic business culture.

Gsk in pakistan

• GlaxoSmithKline Pakistan is one of the leading pharmaceutical companies in Pakistan